IPA (ImmunoPrecise Antibodies) FCF Margin % : -37.67% (As of Oct. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ImmunoPrecise Antibodies's Free Cash Flow for the three months ended in Oct. 2024 was $-1.68 Mil. ImmunoPrecise Antibodies's Revenue for the three months ended in Oct. 2024 was $4.45 Mil. Therefore, ImmunoPrecise Antibodies's FCF Margin % for the quarter that ended in Oct. 2024 was -37.67%.

As of today, ImmunoPrecise Antibodies's current FCF Yield % is -57.21%.

The historical rank and industry rank for ImmunoPrecise Antibodies's FCF Margin % or its related term are showing as below:

IPA' s FCF Margin % Range Over the Past 10 Years
Min: -103.21 Med: -42.07 Max: -11.31
Current: -37.41

During the past 13 years, the highest FCF Margin % of ImmunoPrecise Antibodies was -11.31%. The lowest was -103.21%. And the median was -42.07%.

IPA's FCF Margin % is ranked better than
64.59% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs IPA: -37.41

ImmunoPrecise Antibodies FCF Margin % Historical Data

The historical data trend for ImmunoPrecise Antibodies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies FCF Margin % Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

FCF Margin %

Get a 7-Day Free Trial

-13.99

-11.31

-57.72

-103.21

-23.02

ImmunoPrecise Antibodies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
FCF Margin %	Get a 7-Day Free Trial															-5.15	-13.94	-58.36	-39.66	-37.67

Competitive Comparison of ImmunoPrecise Antibodies's FCF Margin %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunoPrecise Antibodies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's FCF Margin % falls into.

ImmunoPrecise Antibodies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ImmunoPrecise Antibodies's FCF Margin for the fiscal year that ended in Apr. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Apr. 2024 )	/	Revenue (A: Apr. 2024 )
	=	-4.127	/	17.93
	=	-23.02 %

ImmunoPrecise Antibodies's FCF Margin for the quarter that ended in Oct. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Oct. 2024 )	/	Revenue (Q: Oct. 2024 )
	=	-1.677	/	4.452
	=	-37.67 %

ImmunoPrecise Antibodies FCF Margin % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

TQB:Germany TQB:Germany

Address

3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8

Website

https://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.